X-Linked Adrenoleukodystrophy (X-ALD) is a genetic disorder caused by mutations in the ABCD1 gene, which is responsible for transporting very-long-chain fatty acids ...
Nitro-fatty acids (NO 2-FAs) are a class of bioactive lipids that have garnered significant attention due to their potential therapeutic effects, particularly in inflammation and immune response ...
Quentin M. Anstee, B.Sc., M.B.B.S., Ph.D., M.R.C.P.; Ann K. Daly, B.Sc., Ph.D.; Christopher P. Day, B.A.,M.B., B.Chir.,M.A. (Cambridge), Ph.D.,M.D., F.R.C.P., F.Med ...
HSCT may be a suitable treatment for X-linked ALD adults with early signs of cerebral involvement. Very long-chain fatty acid levels and adrenoleukodystrophy protein (ALDP)-deficiency are strongly ...
leeds.ac.uk Omega (ω)-3 polyunsaturated fatty acids (PUFAs) are naturally occurring substances that are well tolerated and have been used extensively for the prevention of cardiovascular disease. More ...
Bluebird bio could be just a few months away from approval of its gene therapy for rare disease cerebral adrenoleukodystrophy (CALD) in the EU, after the EMA started an accelerated review.
It's early in 2025 and already, there are a huge deal of upcoming Xbox Series X games on the way. February will see a slew of new games land on the platform and Game Pass, with Obsidian's own RPG ...